Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (5): 829-831. doi: 10.19723/j.issn.1671-167X.2022.05.008

Previous Articles     Next Articles

占国 栗*(),立敏 任   

  • Received:2022-06-10 Online:2022-10-18 Published:2022-10-14
  • Contact: 占国 栗 E-mail:li99@bjmu.edu.cn

RICH HTML

  

CLC Number: 

  • R593.2
1 Favero M , Belluzzi E , Ortolan A , et al. Erosive hand osteoarthritis: latest findings and outlook[J]. Nat Rev Rheumatol, 2022, 18 (3): 171- 183.
doi: 10.1038/s41584-021-00747-3
2 Cavasin F , Punzi F , Ramonda R , et al. Prevalence of erosive osteoarthritis of the hand in a population from Venetian area[J]. Reumatismo, 2004, 56 (1): 46- 50.
3 Kwok WY , Kloppenburg M , Marshall M , et al. Comparison of clinical burden between patients with erosive hand osteoarthritis and inflammatory arthritis in symptomatic community-dwelling adults: the Keele clinical assessment studies[J]. Rheumatology, 2013, 52 (12): 2260- 2267.
doi: 10.1093/rheumatology/ket267
4 Marshall M , Peat G , Nicholls E , et al. Subsets of symptomatic hand osteoarthritis in community-dwelling older adults in the United Kingdom: prevalence, inter-relationships, risk factor profiles and clinical characteristics at baseline and 3-years[J]. Osteoarthritis Cartilage, 2013, 21 (11): 1674- 1684.
doi: 10.1016/j.joca.2013.08.004
5 张晓盈, 郅新, 穆荣, 等. 侵蚀性手骨关节炎的临床及影像学特征分析[J]. 中华风湿病杂志, 2017, 21 (7): 455- 460.
6 Punzi L , Ramonda R , Sfriso P . Erosive osteoarthritis[J]. Best Pract Res Clin Rheumatol, 2004, 18 (5): 739- 758.
doi: 10.1016/j.berh.2004.05.010
7 Wittoek R , Cruyssen BV , Verbruggen G . Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis[J]. Arthritis Rheum, 2012, 64 (5): 1430- 1436.
doi: 10.1002/art.33502
8 Haugen IK , Mathiessen A , Slatkowsky-Christensen B , et al. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype[J]. Osteoarthritis Cartilage, 2016, 24 (4): 647- 654.
doi: 10.1016/j.joca.2015.11.014
9 Gazeley DJ , Yeturi S , Patel PJ , et al. Erosive osteoarthritis: a systematic analysis of definitions used in the literature[J]. Semin Arthritis Rheum, 2017, 46 (4): 395- 403.
doi: 10.1016/j.semarthrit.2016.08.013
10 Stern AG , de Carvalho MRC , Buck GA , et al. Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta[J]. Osteoarthritis Cartilage, 2003, 11 (6): 394- 402.
doi: 10.1016/S1063-4584(03)00054-2
11 Ramonda R , Musacchio E , Campana C , et al. Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy[J]. Scand J Rheumatol, 2011, 40 (2): 139- 144.
doi: 10.3109/03009742.2010.507216
12 Kedor C , Detert J , Rau R , et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OATREAT study: a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial[J]. RMD Open, 2021, 7 (2): e001660.
doi: 10.1136/rmdopen-2021-001660
13 Ferrero S , Wittoek R , Allado E , et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial[J]. Semin Arthritis Rheum, 2021, 51 (4): 831- 838.
doi: 10.1016/j.semarthrit.2021.04.016
14 Favero M , Hoxha A , Frallonardo P , et al. Efficacy and safety of ultrasound-guided intra-articular glucocorticoid injection in erosive hand osteoarthritis[J]. Pain Med, 2021, 22 (5): 1229- 1232.
doi: 10.1093/pm/pnaa261
15 Aitken D , Laslett LL , Pan f , et al. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoarthritis: the HUMOR trial[J]. Osteoarthritis Cartilage, 2018, 26 (7): 880- 887.
doi: 10.1016/j.joca.2018.02.899
16 Verbruggen G , Wittoek R , Vander-Cruyssen B , et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification[J]. Ann Rheum Dis, 2012, 71 (6): 891- 898.
doi: 10.1136/ard.2011.149849
17 Kloppenburg M , Ramonda R , Bobacz K , et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial[J]. Ann Rheum Dis, 2018, 77 (12): 1757- 1764.
doi: 10.1136/annrheumdis-2018-213202
18 Kloppenburg M , Peterfy C , Haugen IK , et al. Phase Ⅱ a, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis[J]. Ann Rheum Dis, 2019, 78 (3): 413- 420.
doi: 10.1136/annrheumdis-2018-213336
[1] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[2] Jiyan CHU, Ping LI, Jing TIAN, Diyu FU, Lin GUO, Rui SUN, Yadi LI. Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 175-183.
[3] Yuan LIU, Guixiu SHI. Change from Sjögren syndrome to Sjögren disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1015-1017.
[4] Yirui LIAN, Jingxuan LIU, Liang ZHAO, Jing ZHAO, Sitian ZANG, Yuhui LI. Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1018-1023.
[5] Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031.
[6] Wenhao LIN, Yang XIE, Fangqing WANG, Shuying WANG, Xiangjun LIU, Fanlei HU, Yuan JIA. Single-cell RNA sequencing of B cells reveals molecular typing in Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1032-1041.
[7] Zhao XIANG, Li YANG, Jing YANG. Untargeted metabolomics reveals differential serum metabolites and metabolic pathways in patients with primary Sjögren syndrome and thrombocytopenia [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1042-1050.
[8] Yayun ZHAO, Mengfan NI, Xue LI, Bei WANG, Gong CHENG, Jing HE, Yuebo JIN. Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1051-1060.
[9] Jiajing PENG, Li CUI. Clinical features and prognosis of sarcoidosis with ocular lesions as the initial manifestation [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1061-1066.
[10] Yajing GAO, Zhengfang LI, Mengsi MA, Lijun WU. Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1067-1073.
[11] Xiaolin WANG, Shaoyi GUO, Dazhao CHEN, Xijie WEN, Yong HUA, Liang ZHANG, Qin ZHANG. A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1081-1088.
[12] Xinfeng WU, Siliang MAN, Dazhao CHEN, Yong HUA, Xijie WEN, Yingyue DING, Liang ZHANG, Xiujuan HOU. A long-term review for radiographic parameters of hips in axial spondyloarthritis patients with end-stage hip involvement: A 24-year trend analysis from a single high-volume tertiary center [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1089-1095.
[13] Jingwen LAN, Zhe CHEN, Yongjing CHENG, Like ZHAO. Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1101-1106.
[14] Yanyan LI, Xiangjun LIU, Gongming LI, Chun LI, Yuan JIA. Clinic behavior and therapeutic status of patients with antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1107-1112.
[15] Chun WEI, Yue YANG, Xinju ZHAO, Xu LIU, Yuan JIA. Systemic lupus erythematosus complicated by autoimmune nodopathy: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1174-1179.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!